U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06907849) titled '124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome' on March 26.
Brief Summary: This clinical trial will use the amyloid-binding radiotracer, 124I-evuzamitide, to potentially detect amyloid, in the heart and elsewhere, in patients who have a history of lumbar spinal stenosis and/or carpal tunnel syndrome.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Lumbar Spinal Stenosis
Carpal Tunnel Syndrome (CTS)
Cardiac Amyloidosis
Intervention:
DRUG: 124I-evuzamitide
124I-evuzamitide is an iodine-124 (124I) labeled 45 L-amino acid peptide (also known as p5+14) suitab...